Jazz Pharmaceuticals (JAZZ) EBT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.52% |
| Dec 31, 2025 | 2,207.37% |
| Sep 30, 2025 | 101.23% |
| Jun 30, 2025 | -569.90% |
| Mar 31, 2025 | -182.42% |
| Dec 31, 2024 | -33.66% |
| Sep 30, 2024 | 45.59% |
| Jun 30, 2024 | 8,709.68% |
| Mar 31, 2024 | -102.60% |
| Dec 31, 2023 | -38.18% |
| Sep 30, 2023 | 21.68% |
| Jun 30, 2023 | 48.43% |
| Mar 31, 2023 | 116.21% |
| Dec 31, 2022 | -465.43% |
| Sep 30, 2022 | -386.14% |
| Jun 30, 2022 | 232.24% |
| Mar 31, 2022 | 114.11% |
| Dec 31, 2021 | 33.72% |
| Sep 30, 2021 | 50.29% |
| Jun 30, 2021 | -200.28% |
| Mar 31, 2021 | -6.30% |
| Dec 31, 2020 | -13.88% |
| Sep 30, 2020 | -1.93% |
| Jun 30, 2020 | 181.92% |
| Mar 31, 2020 | -613.41% |
| Dec 31, 2019 | -64.30% |
| Sep 30, 2019 | -37.97% |
| Jun 30, 2019 | 59.81% |
| Mar 31, 2019 | -30.37% |
| Dec 31, 2018 | -2.15% |
| Sep 30, 2018 | 30.65% |
| Jun 30, 2018 | 97.68% |
| Mar 31, 2018 | -44.95% |
| Dec 31, 2017 | 82.85% |
| Sep 30, 2017 | -53.98% |
| Jun 30, 2017 | 22.01% |
| Mar 31, 2017 | -23.45% |
| Dec 31, 2016 | 30.03% |
| Sep 30, 2016 | -25.70% |
| Jun 30, 2016 | 44.81% |
| Mar 31, 2016 | 12.06% |
| Dec 31, 2015 | -18.15% |
| Sep 30, 2015 | -0.72% |
| Jun 30, 2015 | 15.57% |
| Mar 31, 2015 | -10.83% |
| Dec 31, 2014 | 130.54% |
| Sep 30, 2014 | -20.57% |
| Jun 30, 2014 | 182.15% |
| Sep 30, 2013 | 42.49% |
| Jun 30, 2013 | 7.75% |
| Mar 31, 2013 | 6.29% |
| Dec 31, 2012 | 23.67% |
| Sep 30, 2012 | 23.19% |
| Jun 30, 2012 | 5.47% |
| Mar 31, 2012 | -4.59% |
| Dec 31, 2011 | 15.37% |
| Sep 30, 2011 | -2.17% |
| Jun 30, 2011 | 52.11% |
| Mar 31, 2011 | 63.16% |
| Dec 31, 2010 | 1.02% |
| Sep 30, 2010 | 28.19% |